Shigematsu Works Co., Ltd. (TYO:7980)
935.00
-13.00 (-1.37%)
May 13, 2026, 3:30 PM JST
Shigematsu Works Revenue
In the fiscal year ending March 31, 2026, Shigematsu Works had annual revenue of 15.59B JPY with 10.49% growth. Shigematsu Works had revenue of 5.15B in the quarter ending March 31, 2026, with 16.46% growth.
Revenue
15.59B
Revenue Growth
+10.49%
P/S Ratio
0.43
Revenue / Employee
39.98M
Employees
390
Market Cap
6.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 15.59B | 1.48B | 10.49% |
| Mar 31, 2025 | 14.11B | 1.12B | 8.60% |
| Mar 31, 2024 | 13.00B | 120.00M | 0.93% |
| Mar 31, 2023 | 12.88B | 957.00M | 8.03% |
| Mar 31, 2022 | 11.92B | -781.00M | -6.15% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medius Holdings | 295.20B |
| JMS Co.,Ltd. | 66.09B |
| SEED Co.,Ltd. | 33.57B |
| Medikit | 23.68B |
| Daiken Medical | 10.17B |
| Platz | 8.37B |
| Sincere Co., LTD. | 7.46B |
| KAINOS Laboratories | 4.44B |